HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹33 Cr | ₹30 Cr | ₹33 Cr | ₹36 Cr | ₹38 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of HIKAL ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹30 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹36 Cr |
| Mar2021 | ₹38 Cr |
How is Deferred Tax Assets / Liabilities of HIKAL Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹33 Cr | 8.33 | |
| Mar2024 | ₹30 Cr | -8.30 | |
| Mar2023 | ₹33 Cr | -10.14 | |
| Mar2022 | ₹36 Cr | -3.13 | |
| Mar2021 | ₹38 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,358.7 Cr | -4.3% | -15.7% | -46.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -2.8% | -7.5% | -12.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | -0.6% | -5.5% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -2.5% | 3.5% | 21.1% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3.7% | -11.7% | -8.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | -0.7% | -4.7% | -5.1% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -4.3% |
-15.7% |
-46.6% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses